Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
55.28
-0.45 (-0.81%)
At close: Feb 4, 2026, 4:00 PM EST
55.28
0.00 (0.00%)
After-hours: Feb 4, 2026, 6:01 PM EST
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $7.94 billion as of February 4, 2026. Its market cap has decreased by -25.36% in one year.
Market Cap
7.94B
Enterprise Value
6.11B
1-Year Change
-25.36%
Ranking
Category
Stock Price
$55.28
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $7.94B, an increase of 475.07%. That is a compound annual growth rate of 36.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 8.00B | 32.46% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 9.52B |
| Axsome Therapeutics | 9.33B |
| ABIVAX Société Anonyme | 8.77B |
| Praxis Precision Medicines | 8.59B |
| Halozyme Therapeutics | 8.47B |
| Krystal Biotech | 8.10B |
| Nuvalent | 8.02B |
| Cytokinetics | 7.75B |